« Back
Home /
CCT129202

CCT129202

Item no.	HY-12049-5mg
Manufacturer	MedChem Express
CASRN	942947-93-5
Amount	5 mg
Quantity options	100 mg 10mM*1 mL 10 mg 1 mg 50 mg 5 mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Bladder Cancer Colorectal Cancer
Type	Inhibitors
Specific against	other
Purity	98.0
Formula	C23H25ClN8OS
Citations	[1]Chan F, et al. Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3147-57.
Smiles	CN(C1=CC=C(C2=NC3=C(C(Cl)=CN=C3N2)N4CCN(CC4)CC(NC5=NC=CS5)=O)C=C1)C
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	942947-93-5
Available
Product Description	CCT129202 is an aurora kinase inhibitor with IC50s of 42, 198, and 227 nM for aurora A, B and C, respectively.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	497.02
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Solubility	DMSO : 1 mg/mL (ultrasonic)
Target	Aurora Kinase
Manufacturers Target	Aurora Kinase
Isoform	Aurora A; Aurora B; Aurora C
Manufacturers Pathway	Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12049-5mg-safety-datasheet.pdf